1. Application of radially grown ZnO nanowires on poly-<scp>l</scp>-lactide microfibers complexed with a tumor antigen for cancer immunotherapy
- Author
-
Yu Jin Kim, Yuri Kim, Prashant Sharma, Young Keun Kim, Ji Beom Shin, Na Yoon Jang, Jaewon Lee, Bum Chul Park, Nam Hyuk Cho, and Sang Won Byun
- Subjects
Cellular immunity ,Biocompatibility ,Polyesters ,medicine.medical_treatment ,02 engineering and technology ,010402 general chemistry ,T-Lymphocytes, Regulatory ,01 natural sciences ,Nanocomposites ,Mice ,Immune system ,Cancer immunotherapy ,Antigen ,Antigens, Neoplasm ,Cell Line, Tumor ,medicine ,Animals ,General Materials Science ,Drug Carriers ,Immunity, Cellular ,Nanowires ,Chemistry ,Dendritic Cells ,Neoplasms, Experimental ,Immunotherapy ,021001 nanoscience & nanotechnology ,Acquired immune system ,Tumor antigen ,0104 chemical sciences ,Biophysics ,Zinc Oxide ,0210 nano-technology - Abstract
Zinc oxide (ZnO)-based nanocomposites have shown promising potential for various biomedical applications, including vaccine development, owing to their multifunctionality and biocompatibility. Here, we synthesized radially grown ZnO nanowires (NWs) on poly-l-lactic acid (PLLA) microfibers with unique 3-dimensional structure and applied them as therapeutic cancer vaccines. This inorganic-organic hybrid nanocomposite has mild cellular toxicity but efficiently delivers a tumor antigen into dendritic cells, cellular bridges between innate and adaptive immunity, to stimulate them to express inflammatory cytokines and activation surface markers. We also demonstrated that the hybrid nanocomposites successfully induce tumor antigen-specific cellular immunity and significantly inhibit tumor growth in vivo. ZnO NWs on PLLA fibers systemically reduced immune suppressive TReg cells and enhanced the infiltration of T cells into tumor tissues, compared to mice immunized with PLLA fibers coated with the antigen. Our current findings open a new avenue in extending the biomedical application of inorganic metal oxide-inert organic hybrid nanocomposites as a novel vaccine platform.
- Published
- 2019
- Full Text
- View/download PDF